ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

First Test Of Cooperative Groups’ Willingness To Change Coming In New Colorectal Trials

November 14, 1986

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

March 2, 2007

Cancer Support Community Reports on Patient Experiences

October 24, 2014